Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Eaton SE, Kaczmarek J, Mahmood D, McDiarmid AM, Norarfan AN, Scott EG, et al. Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients. Br J Cancer. 2022;127:2087–98.
2. Vodnar DC, Calinoiu LF, Mitrea L. Editorial: exploiting the effect of dietary fibre on the gut microbiota in patients with pelvic radiotherapy. Br J Cancer. 2022;127:1575–6.
3. Murray J, Cruickshank C, Bird T, Bell P, Braun J, Chuter D, et al. PEARLS—a multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation. Clin Transl Radiat Oncol. 2022;37:130–6.
4. Reis Ferreira M, Khan A, Thomas K, Truelove L, McNair H, Gao A, et al. A phase I/II dose escalation study of the use of intensity modulated radiotherapy (IMRT) to treat the prostate and pelvic nodes in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2017; http://linkinghub.elsevier.com/retrieve/pii/S0360301617336556.
5. Hauer-Jensen M, Denham JW, Andreyev HJN. Radiation enteropathy—pathogenesis, treatment and prevention. Nat Rev Gastroenterol Hepatol. 2014;11:470–9.